PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Tissue Engineering and Applied Cell Sciences Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.\', \'Tissue Engineering Department, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran.\', \'Students\' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.\', \'Anatomy Department-School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Internal Medicine Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.\', \'Research Center for Immunodeficiencies, Children\'s Medical Center, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.\', \'Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/08923973.2021.1925906
?:hasPublicationType
?:journal
  • Immunopharmacology and immunotoxicology
is ?:pmid of
?:pmid
?:pmid
  • 34018464
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.711
?:rankingScore_hIndex
  • 41
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-IgE monoclonal antibodies as potential treatment in COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all